Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet
Links shared publicly online about this topic.
- 737total visits
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet
View full resource at thelancet.com
Tags: Alzheimer's Disease Medication, Schizophrenia Medication, Antipsychotic Medication, Exelon, Haldol, Mortality
Most Recently Shared on November 10, 2010 at 7:29 pm By:
Study of Exelon in hosp. delirium stopped due to excess mortality http://bit.ly/adSLBf http://www.thelancet.com/
Psychiatry Article | Haloperidol Mortality
mdlinx.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trial” View full resource at mdlinx.com
Most Recently Shared on November 8, 2010 at 12:16 pm By:
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality i... http://bit.ly/aRmAxm #PSY
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet
thelancet.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...” View full resource at thelancet.com
Most Recently Shared on November 5, 2010 at 7:52 am By:
We have published a study showing Rivastigmine does not decrease delirium and might increase mortality in critical care http://bit.ly/9oD61a
Advertisement

